175 related articles for article (PubMed ID: 18021294)
1. Neurokinin-3 peptide instead of neurokinin-1 synergistically exacerbates kainic acid-inducing degeneration of neurons in the substantia nigra of mice.
Chen LW; Wang YQ; Bian GL; Wei LC; Yung KL
J Neurochem; 2008 Apr; 105(1):203-16. PubMed ID: 18021294
[TBL] [Abstract][Full Text] [Related]
2. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
3. Neurokinin receptor 3 peptide exacerbates 6-hydroxydopamine-induced dopaminergic degeneration in rats through JNK pathway.
Chu JM; Chan YS; Chen LW; Yung KK
J Neurochem; 2012 Nov; 123(3):417-27. PubMed ID: 22762252
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists.
Medhurst AD; Hay DW; Parsons AA; Martin LD; Griswold DE
Br J Pharmacol; 1997 Oct; 122(3):469-76. PubMed ID: 9351503
[TBL] [Abstract][Full Text] [Related]
5. Roles of neuronal NK1 and NK3 receptors in synaptic transmission during motility reflexes in the guinea-pig ileum.
Johnson PJ; Bornstein JC; Burcher E
Br J Pharmacol; 1998 Aug; 124(7):1375-84. PubMed ID: 9723948
[TBL] [Abstract][Full Text] [Related]
6. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
Broccardo M; Improta G; Tabacco A
Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
[TBL] [Abstract][Full Text] [Related]
7. Typical and atypical NK1 tachykinin receptor characteristics in the rabbit isolated iris sphincter.
Hall JM; Mitchell D; Morton IK
Br J Pharmacol; 1994 Jul; 112(3):985-91. PubMed ID: 7522864
[TBL] [Abstract][Full Text] [Related]
8. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
[TBL] [Abstract][Full Text] [Related]
9. Opioid activity of sendide, a tachykinin NK1 receptor antagonist.
Sakurada T; Yuhki M; Inoue M; Sakurada C; Tan-No K; Ohba M; Kisara K; Sakurada S
Eur J Pharmacol; 1999 Mar; 369(3):261-6. PubMed ID: 10225361
[TBL] [Abstract][Full Text] [Related]
10. Role of neurokinin 3 receptors in supraoptic vasopressin and oxytocin neurons.
Howe HE; Somponpun SJ; Sladek CD
J Neurosci; 2004 Nov; 24(45):10103-10. PubMed ID: 15537880
[TBL] [Abstract][Full Text] [Related]
11. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt/PKB cell signaling pathway.
Chu JM; Chen LW; Chan YS; Yung KK
Neuropharmacology; 2011 Dec; 61(8):1389-98. PubMed ID: 21907219
[TBL] [Abstract][Full Text] [Related]
13. Neurokinin-receptor-mediated depolarization of cortical neurons elicits an increase in glutamate release at excitatory synapses.
Stacey AE; Woodhall GL; Jones RS
Eur J Neurosci; 2002 Nov; 16(10):1896-906. PubMed ID: 12453053
[TBL] [Abstract][Full Text] [Related]
14. Canine intrinsic cardiac neurons involved in cardiac regulation possess NK1, NK2, and NK3 receptors.
Thompson GW; Hoover DB; Ardell JL; Armour JA
Am J Physiol; 1998 Nov; 275(5):R1683-9. PubMed ID: 9791091
[TBL] [Abstract][Full Text] [Related]
15. Neurokinin release in the rat nucleus of the solitary tract via NMDA and AMPA receptors.
Colin I; Blondeau C; Baude A
Neuroscience; 2002; 115(4):1023-33. PubMed ID: 12453476
[TBL] [Abstract][Full Text] [Related]
16. Intranigral tachykinin NK3 receptor agonist elicits oral movements in rats.
Liminga U; Johansson PE; Gunne L
Pharmacol Biochem Behav; 1991 Mar; 38(3):617-20. PubMed ID: 1712496
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo characterization of the non-peptide NK3 receptor antagonist SB-223412 (talnetant): potential therapeutic utility in the treatment of schizophrenia.
Dawson LA; Cato KJ; Scott C; Watson JM; Wood MD; Foxton R; de la Flor R; Jones GA; Kew JN; Cluderay JE; Southam E; Murkitt GS; Gartlon J; Pemberton DJ; Jones DN; Davies CH; Hagan J
Neuropsychopharmacology; 2008 Jun; 33(7):1642-52. PubMed ID: 17728699
[TBL] [Abstract][Full Text] [Related]
18. Tachykinin neurokinin-1 and neurokinin-3 receptor-mediated responses in guinea-pig substantia nigra: an in vitro electrophysiological study.
Nalivaiko E; Michaud JC; Soubrié P; Le Fur G; Feltz P
Neuroscience; 1997 Jun; 78(3):745-57. PubMed ID: 9153655
[TBL] [Abstract][Full Text] [Related]
19. Activation of the cloned human NK3 receptor in Chinese Hamster Ovary cells characterized by the cellular acidification response using the Cytosensor microphysiometer.
Jordan RE; Smart D; Grimson P; Suman-Chauhan N; McKnight AT
Br J Pharmacol; 1998 Oct; 125(4):761-6. PubMed ID: 9831912
[TBL] [Abstract][Full Text] [Related]
20. GABAergic basal forebrain neurons that express receptor for neurokinin B and send axons to the cerebral cortex.
Furuta T; Koyano K; Tomioka R; Yanagawa Y; Kaneko T
J Comp Neurol; 2004 May; 473(1):43-58. PubMed ID: 15067717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]